Cannabis
DisposeRx Announces the Expansion of DisposeRx Direct at Rx Summit 2022
DisposeRx, Inc. will begin offering products from Rx Destroyer on its online store, DisposeRx Direct, at the Rx Drug Abuse and Heroin Summit (Rx Summit), April 18-21, 2022, in Atlanta.
Rx Summit is the largest, most influential annual conference addressing the opioid and addiction crisis, and DisposeRx is a gold sponsor. This year’s theme is “It’s Time to Turn This Epidemic Around,” and DisposeRx and Rx Destroyer executives are teaming up to help battle the drug misuse epidemic through medication disposal and education.
“DisposeRx and Rx Destroyer are coming together to share with conference participants comprehensive medication disposal options designed to meet virtually all needs—from individual prescriptions to large quantities,” said William Simpson, president and chief executive officer of DisposeRx, Inc. “We share the same mission, commitment to outstanding customer service and passion for this industry, and we are proud to work together to remove the risks and dangers associated with unused and leftover medications.”
DisposeRx Direct—a wholly-owned subsidiary of DisposeRx, Inc., now includes several of Rx Destroyer’s most popular disposal solutions for large quantities of medications. The companies will showcase their products in Booth 319.
“Rx Summit is a chance to show the world that two businesses that share marketspace can come together for the greater good and especially in the fight to end opioid abuse,” said Milton Dallas, CEO for Rx Destroyer. “Showcasing our products together demonstrates that there are several ways to make a difference, and we must have the will and courage to do so. Some things are bigger than just what is in front of us. Making the world a better place for our loved ones for generations to come is our obligation and responsibility, and this demonstration of both companies’ products is just one of many ways we can make this happen.”
-
Cannabis1 week ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis1 week ago
IM Cannabis Reports First Quarter Financial Results
-
Innocan1 week ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis5 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
Cannabis5 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis4 days ago
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
-
Cannabis3 days ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032
-
Cannabis3 days ago
Rubicon Organics Reports Q1 2024 Financial Results